Table 4 Multivariate analysis of post-recurrence survival.

From: Prognosis of asymptomatic versus symptomatic metastatic breast cancer: a multicenter retrospective study

 

Hazard ratio

95% Confidence interval

p-value

Subtype

Triple negative vs no triple negative

2.563

1.686–3.896

 < 0.001

Recurrence-free survival, year

0.914

0.871–0.959

 < 0.001

Multiple metastasis site vs single metastasis site

1.855

1.316–2.614

 < 0.001

Symptomatic MBC vs Asymptomatic MBC

1.759

1.263–2.451

 < 0.001

  1. MBC metastatic breast cancer.